PT - JOURNAL ARTICLE AU - Gianluca Conte AU - Sebastiano Antonio Pacino AU - Toti Urso AU - Rosalia Emma AU - Pasquale Caponnetto AU - Fabio Cibella AU - Riccardo Polosa TI - REPEATABILITY OF A DIGITAL IMAGING TECHNOLOGY FOR DENTAL PLAQUE QUANTITATION (QRAYCAM™ PRO) IN CURRENT, FORMER AND NEVER SMOKERS – STUDY PROTOCOL AID - 10.1101/2021.01.12.21249560 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.12.21249560 4099 - http://medrxiv.org/content/early/2021/01/15/2021.01.12.21249560.short 4100 - http://medrxiv.org/content/early/2021/01/15/2021.01.12.21249560.full AB - Although the detrimental health effects of smoking on human health are well described, the impact of smoking on dental plaque build-up lacks consistent records. This is because dental research on periodontal health has primarily relied on subjective indices with poor discriminatory power. Novel digital imaging techniques for the objective quantitation of dental plaque are now available. Quantitative Light-Induced Fluorescence (QLF) technology has been used in several studies for digital quantification and monitoring of dental plaque.The objective of the study is to quantitate and compare short- and long-term repeatability of dental plaque among current, former, and never smokers by using a high resolution, auto-focus, hand-held QLF scanner (QRayCam™ Pro; Inspektor Research Systems BV, Amsterdam, NL).Demonstration of good reproducibility of QLF technology with clear discrimination for dental plaque quantitation among current, former, and never smokers will pave the way to future application of this test for both medical and regulatory research applied not only to combustion-free tobacco products (e.g. e-cigarettes, heated tobacco products, oral tobacco/nicotine products, etc.) and smoking cessation medications, but also to consume care product for oral hygiene.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study was not registered in ClinicalTrials.gov considering that is a pilot study, parts of a larger project with ID: NCT04649645Funding StatementECLAT srl, a research spin off company of the University of Catania is the Sponsor of SMILE Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Comitato Etico Catania 2 n. 73/2020/CECT2All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRecruitment of participants started in July 2020 and was completed in November 2020. Final results will be reported in 2021.